News Roundup | Prominent Indian Physician Talks Impact Of Ivermectin In Home Medicine Kits in India

Join The Conversation! | https://trialsitenews.com/
Story 1 | Prominent Indian Physician Talks Impact Of Ivermectin In Home Medicine Kits in India
TrialSite News chronicled closely the use of ivermectin-based home medicine kits in India’s largest state, Uttar Pradesh, and other states during the second wave of the pandemic starting in March and running through April. TrialSite News shared that by June cases plummeted to what is today’s far more contained situation.
Article Link | https://trialsitenews.com/prominent-indian-physician-verifies-huge-impact-of-ivermectin-in-curbing-second-delta-variant-wave-in-india/

Story 2 | FDA Approves First COVID-19 Vaccine: Why Are they Rushing?
The U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
Article Link | https://trialsitenews.com/fda-approves-first-covid-19-vaccine-why-are-they-rushing/